Issued Patents All Time
Showing 1–25 of 45 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12351580 | NLRP3 modulators | Gary D. Glick, Shomir Ghosh, William R. Roush, Daniel O'Malley | 2025-07-08 |
| 11827632 | NLRP3 modulators | Gary D. Glick, Shomir Ghosh, William R. Roush, Daniel O'Malley | 2023-11-28 |
| 11753433 | Methods of synthesizing substituted purine compounds | — | 2023-09-12 |
| 11633420 | Method of treating leukemia | Richard Chesworth, Kevin Wayne Kuntz, Victoria M. Richon, Roy M. Pollock, Scott R. Daigle | 2023-04-25 |
| 11572383 | Methods of synthesizing substituted purine compounds | — | 2023-02-07 |
| 11505571 | Compounds and compositions for treating conditions associated with sting activity | Gary D. Glick, Shomir Ghosh, William R. Roush, Roger Jones | 2022-11-22 |
| 11072612 | NLRP3 modulators | Gary D. Glick, Shomir Ghosh, William R. Roush | 2021-07-27 |
| 10968247 | Methods of synthesizing substituted purine compounds | — | 2021-04-06 |
| 10961270 | Compounds and compositions for treating conditions associated with sting activity | Gary D. Glick, Shomir Ghosh, William R. Roush, Roger Jones | 2021-03-30 |
| 10881680 | Method of treating leukemia | Richard Chesworth, Kevin Wayne Kuntz, Victoria M. Richon, Roy M. Pollock, Scott R. Daigle | 2021-01-05 |
| 10723756 | Cyclic dinucleotides for treating conditions associated with STING activity such as cancer | Gary D. Glick, Shomir Ghosh, William R. Roush, Roger Jones | 2020-07-28 |
| 10604542 | Cyclic dinucleotides for treating conditions associated with sting activity such as cancer | Gary D. Glick, Shomir Ghosh, William R. Roush, Roger Jones | 2020-03-31 |
| 10556903 | NLRP3 modulators | Gary D. Glick, Shomir Ghosh, William R. Roush | 2020-02-11 |
| 10533005 | NLRP3 modulators | Gary D. Glick, Shomir Ghosh, William R. Roush, Daniel O'Malley | 2020-01-14 |
| 10273223 | Substituted 6,5-fused bicyclic heteroaryl compounds | Kevin Wayne Kuntz, Richard Chesworth, Kenneth W. Duncan | 2019-04-30 |
| 10112968 | Inhibitors of protein methyltransferase DOT1L and methods of use thereof | Richard Chesworth, Roy M. Pollock, Lei Jin | 2018-10-30 |
| 9738679 | Methods of synthesizing substituted purine compounds | — | 2017-08-22 |
| 9718788 | Heteroaryl compounds useful as inhibitors of E1 activating enzymes | Christopher F. Claiborne, Stephen Critchley, Steven P. Langston, Hirotake Mizutani, Stephane Peluso +2 more | 2017-08-01 |
| 9701707 | Methods of synthesizing substituted purine compounds | — | 2017-07-11 |
| 9637472 | Substituted 6,5-fused bicyclic heteroaryl compounds | Kevin Wayne Kuntz, Richard Chesworth, Kenneth W. Duncan | 2017-05-02 |
| 9597348 | Method of treating leukemia | Richard Chesworth, Kevin Wayne Kuntz, Victoria M. Richon, Roy M. Pollock, Scott R. Daigle | 2017-03-21 |
| 9458108 | Heteroaryl compounds useful as inhibitors of E1 activating enzymes | Christopher F. Claiborne, Stephen Critchley, Steven P. Langston, Hirotake Mizutani, Stephane Peluso +2 more | 2016-10-04 |
| 9394310 | Carbocycle-substituted purine and 7-deazapurine compounds | Richard Chesworth, Kevin Wayne Kuntz | 2016-07-19 |
| 9206157 | Substituted 6,5-fused bicyclic heteroaryl compounds | Kevin Wayne Kuntz, Richard Chesworth, Kenneth W. Duncan | 2015-12-08 |
| 9175032 | Methods of synthesizing substituted purine compounds | — | 2015-11-03 |